DROXIA Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Droxia, and what generic alternatives are available?
Droxia is a drug marketed by Cheplapharm and is included in one NDA.
The generic ingredient in DROXIA is hydroxyurea. There are ten drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the hydroxyurea profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Droxia
A generic version of DROXIA was approved as hydroxyurea by BARR on October 16th, 1998.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DROXIA?
- What are the global sales for DROXIA?
- What is Average Wholesale Price for DROXIA?
Summary for DROXIA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 159 |
| Clinical Trials: | 13 |
| Patent Applications: | 1,706 |
| Drug Prices: | Drug price information for DROXIA |
| What excipients (inactive ingredients) are in DROXIA? | DROXIA excipients list |
| DailyMed Link: | DROXIA at DailyMed |
Recent Clinical Trials for DROXIA
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Chicago | Phase 1 |
| Mayo Clinic | Phase 2 |
| St. Jude Children's Research Hospital | Phase 2 |
Pharmacology for DROXIA
| Drug Class | Antimetabolite |
US Patents and Regulatory Information for DROXIA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cheplapharm | DROXIA | hydroxyurea | CAPSULE;ORAL | 016295-002 | Feb 25, 1998 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Cheplapharm | DROXIA | hydroxyurea | CAPSULE;ORAL | 016295-003 | Feb 25, 1998 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Cheplapharm | DROXIA | hydroxyurea | CAPSULE;ORAL | 016295-004 | Feb 25, 1998 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
